Delivery Order SPE2DE24DA017-SPE2D625F5U4W
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order on August 11, 2025, for a Fibertak Biceps Implant Set valued at $4,034.95. This fixed-price delivery order with economic price adjustment is set to be completed by August 14, 2025, and will be performed in Naples, Florida. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, with no set-aside designation...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,751.88 for a Fibertak Biceps Implant Set on September 5, 2025, with an ultimate completion date of September 10, 2025. This fixed-price delivery order with economic price adjustment was issued under a non-set-aside competition and will be performed in Naples, Florida. The award was made by the Defense Logistics Agency's Medical Supply Chain, a...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,939.96 for a Fibertak Biceps Implant Set on June 24, 2025, with completion scheduled for June 27, 2025. This fixed-price contract with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal procurement vehicle. The award represents no set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,273.60 for a Fibertak Biceps Implant on August 11, 2025, with an ultimate completion date of August 14, 2025. This fixed-price delivery order with economic price adjustment was funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare needs. The contract carries no set-aside...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $3,524.40 fixed-price delivery order with economic price adjustment for a Fibertak Biceps Implant on June 25, 2025. The contract is set to be completed by June 30, 2025, and will be performed in Naples, Florida. This delivery order was funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with no small business set-aside designation applied....
- Arthrex Inc., a global leader in minimally invasive orthopedic surgical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,824.38 for a Fibertak Biceps Implant Set on August 13, 2025. This fixed-price delivery order with economic price adjustment was issued under a larger Indefinite Delivery Contract (IDC) held by Arthrex with the Defense Logistics Agency's Medical Supply Chain, valued at approximately $471 million and extending through September 1, 2029....
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,201.10 for a Fibertak Biceps Implant on August 29, 2025, with an ultimate completion date of September 4, 2025. This fixed-price delivery order with economic price adjustment falls under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies for the Department of Defense and Veterans...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,128.19 for a Fibertak Biceps Implant Set on November 25, 2025, with completion targeted for December 1, 2025. This fixed-price delivery order with economic price adjustment was issued without set-aside designation and will be performed at the company's Naples facility. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,355.54 for Fibertak biceps implants on June 4, 2025, with an ultimate completion date of June 9, 2025. The contract is fixed-price with economic price adjustment provisions and carries no set-aside designation, reflecting Arthrex's strong competitive standing in the federal healthcare marketplace. The work will be performed in Naples, Florida, and is...
- Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $70,053.15 on June 3, 2025, for Fibertak shoulder products. This fixed-price delivery order with economic price adjustment is set to conclude by June 6, 2025, and will be performed in Naples, FL. The award was issued by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F5U4WDelivery Order
Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $14,287.71 for a Fibertak Biceps Implant Set on May 2, 2025. This fixed-price contract with economic price adjustment is scheduled for completion by May 7, 2025, and will be performed in Naples, Florida. The award was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency responsible for procuring medical supplies and equipment for military and veteran healthcare systems. This delivery order falls under Arthrex's larger Indefinite Delivery Contract with the Defense Logistics Agency (SPE2DE24D0020), a single-award IDC valued at $471.0 million that runs through September 1, 2029. The Fibertak system is a specialized orthopedic implant product used in shoulder surgical procedures, consistent with Arthrex's portfolio of advanced arthroscopic instruments and joint repair technologies. No set-aside designation was applied to this award, reflecting Arthrex's competitive position in the federal orthopedic medical device marketplace. The delivery order represents one of many task orders being executed under the comprehensive IDC, which enables VA medical centers and Department of Defense facilities nationwide to access Arthrex's full range of orthopedic solutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 5/2/25 |